DMK PHARMACEUTICALS CORPORATION — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a5f5a5a1-ee64-4f22-baa0-37748f9baede/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-26.5M | 2022-01-01 – 2022-12-31 | evidence 0001387131-23-003523 |
| FY 2021 | $-45.8M | 2021-01-01 – 2021-12-31 | evidence 0001387131-22-004483 |
| FY 2020 | $-49.4M | 2020-01-01 – 2020-12-31 | evidence 0001387131-21-004529 |
| FY 2019 | $-27.5M | 2019-01-01 – 2019-12-31 | evidence 0001387131-21-004529 |
| FY 2018 | $-39.0M | 2018-01-01 – 2018-12-31 | evidence 0001387131-19-001966 |
| FY 2017 | $-25.5M | 2017-01-01 – 2017-12-31 | evidence 0001387131-18-001080 |
| FY 2016 | $-19.4M | 2016-01-01 – 2016-12-31 | evidence 0001387131-17-001745 |
| FY 2015 | $-13.6M | 2015-01-01 – 2015-12-31 | evidence 0001387131-16-004688 |
| FY 2014 | $-10.8M | 2014-01-01 – 2014-12-31 | evidence 0001387131-16-004688 |
| FY 2013 | $-8.2M | 2013-04-01 – 2014-03-31 | evidence 0001387131-14-002262 |
| FY 2012 | $-7.2M | 2012-04-01 – 2013-03-31 | evidence 0001387131-13-002469 |
| FY 2011 | $-4.9M | 2011-04-01 – 2012-03-31 | evidence 0001387131-12-002016 |
| FY 2010 | $-7.0M | 2010-04-01 – 2011-03-31 | evidence 0001387131-12-002016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
DMK PHARMACEUTICALS CORPORATION — all facts · Revenue · Operating Income